The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Doxorubicin 2mg/ml Concentrate for Solution for Infusion

2 milligram(s)/millilitre Concentrate for solution for infusion

Seacross Pharma (Europe) LtdPA22766/004/001

Main Information

Trade NameDoxorubicin 2mg/ml Concentrate for Solution for Infusion
Strength2 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderSeacross Pharma (Europe) Ltd
Licence NumberPA22766/004/001

Group Information

ATC CodeL01DB Anthracyclines and related substances
L01DB01 doxorubicin


Licence Issued29/01/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back